ENDRA Life Sciences (NDRA) Non-Current Debt (2020 - 2023)
ENDRA Life Sciences (NDRA) posted quarterly Non-Current Debt of $281154.0 for Q2 2023, up 887.06% year-over-year from $28484.0 in Q2 2022, and down 13.24% quarter-over-quarter from $324064.0 in Q1 2023.
ENDRA Life Sciences (NDRA) Non-Current Debt (2020 - 2023) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Non-Current Debt for 4 consecutive years, with $281154.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Non-Current Debt rose 887.06% year-over-year to $281154.0; the TTM figure through Jun 2023 stood at $281154.0 (up 887.06% YoY), while the FY2021 annual figure was $546631.0, up 62.16% from the prior year.
- Non-Current Debt slipped to $281154.0 in Q2 2023 per NDRA's latest filing, from $324064.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $614677.0 in Q2 2021 and bottomed at $28484.0 in Q1 2021.
- Historically, Non-Current Debt has averaged $283484.7 across 4 years, with a median of $330574.0 in 2020.
- On a YoY basis, Non-Current Debt climbed as much as 1690.84% in 2022 and fell as far as 95.37% in 2022.
- ENDRA Life Sciences' Non-Current Debt stood at $337084.0 in 2020, then jumped by 62.16% to $546631.0 in 2021, then sank by 94.79% to $28484.0 in 2022, then jumped by 887.06% to $281154.0 in 2023.
- Business Quant data shows NDRA's Non-Current Debt at $281154.0 in Q2 2023, $324064.0 in Q1 2023, and $28484.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 26.56 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 3.05 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 13.71 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 299.87 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.49 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.04 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.86 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 281,154.00 |
| Mar 31, 2023 | 324,064.00 |
| Sep 30, 2022 | 434,257.00 |
| Jun 30, 2022 | 472,652.00 |
| Mar 31, 2022 | 510,102.00 |
| Dec 31, 2021 | 546,631.00 |
| Sep 30, 2021 | 581,314.00 |
| Jun 30, 2021 | 614,677.00 |
| Mar 31, 2021 | 28,484.00 |
| Dec 31, 2020 | 608,992.00 |
| Sep 30, 2020 | 337,084.00 |
| Jun 30, 2020 | 337,084.00 |